title: Over-the-counter availability of Plan B emergency contraception: further discussion and commentary.
abstract: The controversy surrounding the potential switch of the Plan B emergency contraceptive therapy from prescription to over-the-counter status has been unprecedented. Regulatory, professional, and societal aspects of this issue have been discussed recently and will no doubt continue to be debated. In this editorial, members of the Medicine, Law, and Ethics panel of The Annals of Pharmacotherapy's Editorial Board offer a sampling of viewpoints touching on varying aspects of the controversy. Readers may wish to consider the ramifications of their professional decisions in this and similar situations in advance of having to make such decisions.
authors.forename: Jack E
authors.initials: JE
authors.lastname: Fincham
authors.forename: Curtis E
authors.initials: CE
authors.lastname: Harris
authors.forename: William E
authors.initials: WE
authors.lastname: Fassett
authors.forename: Warren
authors.initials: W
authors.lastname: Richards
mesh_terms: D003281:Contraceptives, Postcoital / Q000600:supply & distribution; D006801:Humans; D016912:Levonorgestrel / Q000600:supply & distribution; D004366:Nonprescription Drugs / Q000600:supply & distribution
chemical_list: D003281:Contraceptives, Postcoital; D004366:Nonprescription Drugs; D016912:Levonorgestrel